Status:
COMPLETED
Prevalence and Characteristics of Pulmonary Embolism on COVID-19 Patients Presenting Respiratory Symptoms
Lead Sponsor:
Fondation Hôpital Saint-Joseph
Conditions:
Pulmonary Embolism
Covid-19
Eligibility:
All Genders
18+ years
Brief Summary
Multicentric case-control study that is aims at: * evaluating the prevalence of pulmonary embolism among a large population of consecutive patients admitted for COVID-19 pneumonia into two large univ...
Detailed Description
In December 2019, China reported the first cluster of severe acute respiratory syndrome due to a new coronavirus (SARS-CoV-2). The disease rapidly spread into a global pandemic of public health emerge...
Eligibility Criteria
Inclusion
- patients \>18 years,
- admitted for acute COVID-19 pneumonia and have recieved a chest CT scan during hospitalization,
- COVID-19 diagnosis confirmed by a positive result of a RT-PCR,
- CT findings of COVID-19 pneumonia.
Exclusion
- Respiratory distress syndrome explained by other cause
- Patients who refuse to participate to the study.
Key Trial Info
Start Date :
March 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 20 2020
Estimated Enrollment :
1024 Patients enrolled
Trial Details
Trial ID
NCT04420312
Start Date
March 1 2020
End Date
April 20 2020
Last Update
June 25 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Groupe Hospitalier Paris Saint-Joseph
Paris, France, 75014